0QGJ.L - Medigene AG

LSE - LSE Delayed price. Currency in EUR
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-37.26%
S&P500 52-week change 36.21%
52-week high 32.7400
52-week low 30.0000
50-day moving average 32.0048
200-day moving average 32.1777

Share statistics

Avg vol (3-month) 37
Avg vol (10-day) 35
Shares outstanding 524.56M
Implied shares outstanding 6N/A
Float 822.9M
% held by insiders 16.67%
% held by institutions 14.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.25:1
Last split date 303 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -26.66%
Operating margin (ttm)37.38%

Management effectiveness

Return on assets (ttm)13.14%
Return on equity (ttm)-20.36%

Income statement

Revenue (ttm)31.25M
Revenue per share (ttm)1.27
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)29.26M
Net income avi to common (ttm)-8.33M
Diluted EPS (ttm)-0.4060
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.22M
Total cash per share (mrq)1.35
Total debt (mrq)3.73M
Total debt/equity (mrq)10.06
Current ratio (mrq)5.02
Book value per share (mrq)1.51

Cash flow statement

Operating cash flow (ttm)11.98M
Levered free cash flow (ttm)25.11M